The Mesothelioma Center News – Page 16
-
news
Legislation & LitigationTo eliminate future funding obligations, Honeywell International Inc. has agreed to a one-time, lump sum payment of $1.325 billion to the asbestos trust… -
news
Research & Clinical TrialsLooking Beyond Clinical Trials for Mesothelioma Treatment
Clinical trial results should not always be the guiding force when a mesothelioma cancer patient and their medical team determine what therapy path… -
news
Research & Clinical TrialsGlobal Mesothelioma Cases Nearly Double Over 30 Years
The number of people in the world diagnosed annually with mesothelioma cancer has almost doubled in the last 30 years, accentuating the need… -
news
Research & Clinical TrialsLatest Study Compares Major Pleural Mesothelioma Surgeries
Mesothelioma patients may benefit more from aggressive extrapleural pneumonectomy surgery than from the lung-sparing pleurectomy and decortication currently being recommended as an alternative by… -
news
Asbestos Exposure & BansCongress Resumes Asbestos Ban Efforts After ProPublica Report
U.S. lawmakers and public health advocates have renewed their call for Congress to pass a long-awaited legislative ban of asbestos, sparked by the… -
news
Research & Clinical TrialsNew Research Focuses on Mesothelioma Brain Metastasis
Distant metastasis is common with malignant pleural mesothelioma – more than 60% of patients experience it – but rarely is it found around… -
news
Research & Clinical TrialsLatest Mesothelioma T-Cell Clinical Trial Moves to Phase II
The most recent T-cell therapy aimed at mesothelioma cancer has advanced to phase II of the clinical trial process, with researchers exploring its… -
news
Research & Clinical TrialsStudy: Cancer Enzyme Slows Growth of Pleural Mesothelioma
Patients with pleural mesothelioma may extend their survival by an estimated 30% when the latest anti-cancer enzyme is added to standard chemotherapy, according… -
news
Research & Clinical TrialsOrphan Drug Designation Given to New Mesothelioma CAR T-Cell Therapy
In early 2023, the world-class Hospital of the University of Pennsylvania will open a groundbreaking clinical trial for mesothelioma patients utilizing a next-generation… -
news
Legislation & LitigationU.S. Court of Appeals Hears Challenge to J&J’s Bankruptcy Plan
Johnson & Johnson’s controversial bankruptcy filing, designed to limit its soaring talc liabilities, was challenged Sept. 26 before the United States Court of Appeals…